Immunotech Biopharm Ltd (HKG:6978)
Hong Kong · Delayed Price · Currency is HKD 2.350
-0.050 (-2.08%)
At close: Mar 6, 2026
Immunotech Biopharm Market Cap
Immunotech Biopharm has a market cap or net worth of 1.45 billion as of March 6, 2026. Its market cap has increased by 9.30% in one year.
Market Cap
1.45B
Enterprise Value
1.90B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.35
Market Cap Chart
Since July 10, 2020, Immunotech Biopharm's market cap has decreased from 7.74B to 1.45B, a decrease of -81.25%. That is a compound annual growth rate of -25.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.45B | -19.80% |
| Dec 31, 2025 | 1.81B | 52.87% |
| Dec 31, 2024 | 1.18B | -54.00% |
| Dec 29, 2023 | 2.57B | 7.99% |
| Dec 30, 2022 | 2.38B | -72.51% |
| Dec 31, 2021 | 8.67B | 50.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.96B |
| Zhaoke Ophthalmology | 1.74B |
| Mabpharm | 1.65B |
| Cutia Therapeutics | 1.60B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.50B |
| CANbridge Pharmaceuticals | 1.40B |
| Wuhan YZY Biopharma | 1.39B |
| Beijing Biostar Pharmaceuticals | 1.33B |